Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

SAMN03290914

350e15f8-6c8f-546d-8f3a-f235dd233ca6

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
cancer_type_detailed
subtype

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • INTERFERON_ALPHA_RESPONSE+0.400
  • INTERFERON_GAMMA_RESPONSE+0.200
  • ALLOGRAFT_REJECTION+0.100
  • PANCREAS_BETA_CELLS+0.100
  • ANDROGEN_RESPONSE+0.000
  • HEDGEHOG_SIGNALING+0.000
  • KRAS_SIGNALING_DN+0.000
  • PROTEIN_SECRETION+0.000
  • SPERMATOGENESIS+0.000
  • BILE_ACID_METABOLISM-0.100

Top 10 suppressed

  • ANGIOGENESIS-0.500
  • EPITHELIAL_MESENCHYMAL_TRANSITION-0.500
  • ADIPOGENESIS-0.400
  • APICAL_JUNCTION-0.400
  • CHOLESTEROL_HOMEOSTASIS-0.400
  • E2F_TARGETS-0.400
  • ESTROGEN_RESPONSE_EARLY-0.400
  • ESTROGEN_RESPONSE_LATE-0.400
  • G2M_CHECKPOINT-0.400
  • GLYCOLYSIS-0.400

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

9 twins match this tumor's tissue · 1 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1SAMN03290916
melanoma-umap@29
0.906
2SRR25617833
breast-umap@18
B0.898
3SRR12202414
bladder-landscape@3
0.883
4SRR33346946
bladder-landscape@3
0.880
5SRR11296732
colon-landscapes@1
0.870
6AUR-AD9G-TTP1-B-4-0-R-A584-39
breast-umap@18
D0.867
7MDT-AP-1327
medullo-epn-umap@date-based
MedMedulloblastoma0.866
8TCGA-MP-A4T6-01A-32R-A262-07
lung-landscapes@6
cohortA10.864
9ERR2208899
melanoma-umap@29
0.859
10AUR-AF9A-TTP1-A-1-0-R-A741-41
breast-umap@18
D0.858

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 4 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
INTERFERON_ALPHA_RESPONSE0.400Inavolisib— uncovered
INTERFERON_GAMMA_RESPONSE0.200Idelalisib— uncovered
ALLOGRAFT_REJECTION0.100Idelalisib— uncovered
PANCREAS_BETA_CELLS0.100Cobimetinib— uncovered